Proshares Trust ZBIO
ZBIO
$28.30 +0.35 (+1.27%)
At close: Oct 2, 2026 · 4:00 PM EDT

Zenas BioPharma (ZBIO) Invested Capital (2025 - 2026)

Updated

Zenas BioPharma (ZBIO) reported Invested Capital of $470.05 million for Q2 2026, down 11.2% from the prior quarter.

Analysis

Zenas BioPharma (ZBIO) Invested Capital (2025 - 2026) Analysis & Trends

For FY2025, Zenas BioPharma posted Invested Capital of $320.78 million.

  • Five-year quarterly Invested Capital spans a low of $269.42 million in Q3 2025 and a high of $529.46 million in Q1 2026.
  • Per Business Quant data, the three quarters before Q2 2026 came in at $529.46 million (Q1 2026), $320.78 million (Q4 2025) and $269.42 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Invested Cap. (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn 88.79 Bn
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn 134.01 Bn
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn 64.89 Bn
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn 95.89 Bn
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn 79.44 Bn
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn 50.26 Bn
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn 68.99 Bn
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn 38.08 Bn
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn 148.69 Bn
10 Zenas BioPharma 1.77 Bn 1.77 Bn - 470.05 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 470.05 Mn
Mar 31, 2026 529.46 Mn
Dec 31, 2025 320.78 Mn
Sep 30, 2025 269.42 Mn
API Access

Zenas BioPharma Invested Capital API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=invested-capital&ticker=ZBIO&period=max&api_key=YOUR_API_KEY